Skip to main content
Katherine High, MD, Pediatric Hematology & Oncology, Philadelphia, PA, Hospital of the University of Pennsylvania

KatherineAHighMD

Pediatric Hematology & Oncology • Philadelphia, PA

Professor, Pediatrics, Perelman School of Medicine

Join to view full profile

Dr. High is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. High's full profile

Already have an account?

  • Office

    3401 Civic Center Blvd
    Children's Hospital Of Philadelphia - Hem/Onc
    Philadelphia, PA 19104
    Phone+1 215-590-3535
    Fax+1 215-590-3992
  • Is this information wrong?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1984
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1978 - 1981
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1978

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1992 - 2024
  • NC State Medical License
    NC State Medical License 1981 - 1998
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2007
  • Elected Member The American Society for Clinical Investigation, 1991
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year
    Katherine A. High, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Hemostasis and Thrombosis Poster Walk for Trainees 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Activity of a FIX-Padua Transgene Product in Commonly Used FIX:C One-Stage and Chromogenic Assay Systems Following PF-06838435 (SPK-9001) Gene Delivery 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Biologic Therapeutics Seminar Series - Systems Approaches to Antibody-based Immunotherapy of Cancer 
    Washington University School of Medicine, Saint Louis, Missouri - 5/16/2012

Press Mentions

  • Children's Hospital of Philadelphia Awards Gold Medal to Dr. Katherine High, Gene Therapy Pioneer
    Children's Hospital of Philadelphia Awards Gold Medal to Dr. Katherine High, Gene Therapy PioneerMay 13th, 2022
  • Lab Notes: Gene Therapy Milestone Celebrated; CHOP Honors Pioneer Dr. Katherine High
    Lab Notes: Gene Therapy Milestone Celebrated; CHOP Honors Pioneer Dr. Katherine HighMay 13th, 2022
  • Algae Proteins Partially Restore Blind Man’s Vision, Study Says
    Algae Proteins Partially Restore Blind Man’s Vision, Study SaysMay 27th, 2021
  • Join now to see all

Grant Support

  • Gene Therapy For Hemophilia Using Muscle-Expressed FviiaNational Heart, Lung, And Blood Institute2011
  • Administrative Core For Gene Therapy Of HemophiliaNational Heart, Lung, And Blood Institute2011
  • Immune Responses To Capsid In Aav-Mediated Gene TransferNational Heart, Lung, And Blood Institute2010–2011
  • Pediatric Hematology Research Training ProgramNational Heart, Lung, And Blood Institute2004–2011
  • Gene Therapy For HemophiliaNational Heart, Lung, And Blood Institute2004–2011
  • Clinical Trials Training SymposiumNational Heart, Lung, And Blood Institute2010
  • Pathway To Accelerate Clinical Development In Gene Transfer: CGMP Vector CoreNational Center For Research Resources2010
  • Safety &Efficacy Of Intravas. Del. Of Aav-F.Ix To Skeletal MuscleNational Heart, Lung, And Blood Institute2005–2009
  • Immune Responses To AAV In Gene Transfer For HemophiliaNational Heart, Lung, And Blood Institute2005–2009
  • Biological Roles Of Factors X And XANational Heart, Lung, And Blood Institute2004–2007
  • Administrative CoreNational Heart, Lung, And Blood Institute2005
  • Core A- Administrative CoreNational Heart, Lung, And Blood Institute2004
  • AAV Mediated Muscle Directed Gene Therapy For Hemophilia BNational Heart, Lung, And Blood Institute2004
  • Gene Therapy For HemophiliaNational Heart, Lung, And Blood Institute2000–2003
  • Pediatric Hematology Research Training ProgramNational Heart, Lung, And Blood Institute1997–2003
  • Gene Based Approach To Treating Hemophilic InhibitorsNational Heart, Lung, And Blood Institute2000–2002
  • Core--TrainingNational Heart, Lung, And Blood Institute2000–2002
  • AAV Mediated Muscle Directed Gene Therapy For Hemophilia BNational Heart, Lung, And Blood Institute2000–2002
  • Inhibitor Formation In Gene Therapy For HemophiliaNational Heart, Lung, And Blood Institute1998–2001
  • Gene Therapy Of Hemophilia B Using Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1996–2000
  • Molecular Interactions Of Blood Coagulation Factor XANational Heart, Lung, And Blood Institute1996–1999
  • Novel Stratagies For Gene Therapy Of Hemophilia BNational Heart, Lung, And Blood Institute1994–1998
  • Regulation &Biosynthesis Of Vitamin K-Dependent FactorsNational Heart, Lung, And Blood Institute1992–1995
  • Regulation &Biosynthesis Of Vitamin K-Dependent FactorsNational Heart, Lung, And Blood Institute1992
  • Factor Ix--Molecular Defects &Regulation Of ExpressionNational Heart, Lung, And Blood Institute1988–1991
  • Factor IX: Molecular Defects And Regulation Of ExpressiNational Heart, Lung, And Blood Institute1987

Hospital Affiliations

Dr. Katherine High, Dr. Katherine High, MD, Dr. K High, Dr. Katherine A High